ABVC — ABVC Biopharma Share News
0.000.00%
Last trade - 00:00Brief: ABVC Biopharma Announces Pricing Of $1.75 Million Offering
Brief: ABVC Signs Term Sheet To Acquire Real Estate Assets
Brief: Abvc Biopharma Says Nasdaq Granted Co An Extension To Comply With A Listing Rule
ABVC BioPharma rises after CEO appointment
Brief: ABVC Biopharma Inc Announces Appointment Of Uttam Yashwant Patil As Chief Executive Officer
Brief: Abvc Biopharma Inc - Dr. Howard Doong, The Chief Executive Officer (“CEO”) Of Co Notified The Company Of His Resignation, Effective June 21, 2023
Brief: ABVC Biopharma ADHD Phase II Part 2 Clinical Study First Subject Enrolled
Brief: ABVC Biopharma Says Vitargus Phase II Study On Hold Due To Serious Adverse Events
Abvc Biopharma Rises On Unit's Tie: up with MerDury BioPharma
Brief: ABVC Biopharma Announces Collaboration With Merdury Biopharma
Brief: ABVC Biopharma Receives Deficiency Letter From Nasdaq Listing Qualifications Department
Abvc Biopharma Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview
Brief: Abvc Biopharma Receives US Certificate Of PDC-1421 For The Treatment Of Major Depressive Disorder
Brief: ABVC BioPharma Announces Completion of Phase II Part 2 Clinical Study Site Initiation Visit at UCSF
Brief: Abvc Biopharma Provides Abv-1601 Update On Phase I Site Initiation Visit Conducted At Cedars-Sinai Medical Center
Abvc Biopharma Inc Reports Results For The Quarter Ended In December: Earnings Summary
Abvc Biopharma Inc Expected To Post A Loss Of 15 Cents A Share: Earnings Preview
Abvc Biopharma Inc Expected To Post A Loss Of 15 Cents A Share: Earnings Preview
Brief: ABVC BioPharma Provides Vitargus Update On Phase II Site Initiation Visit Conducted At Srinagarind Hospital In Thailand